Analyst Jami Rubin is focused on the Healthcare sector with 196 price targets and ratings documented since 2012 spanning on 12 stocks. Previously, Jami Rubin worked at GOLDMAN SACHS. Analyst's average stock valuation to be materialised ratio is 81.11% with an average time for price targets to be met of 494.67 days.
Most recent stock forecast was given on TEVA, Teva Pharmaceutical Industries Limited at 01-Oct-2018.
Jami Rubin best performing recommendations are on PRGO (PERRIGO COMPANY PLC).
The best stock recommendation documented was for PRGO (PERRIGO COMPANY PLC) at 1/30/2017. The price target of $75 was fulfilled within 16 days with a profit of $8.03 (11.99%) receiving and performance score of 7.49.
Average potential price target upside
Currently, out of the existing stock ratings of Jami Rubin - 7544 which are a Buy (56.16%), 3484 which are a Hold (25.94%), 2404 which are a Sell (17.9%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
172
$13.75 (8.69%)
166
28 days ago
23/24 (95.83%)
$22.93 (27.45%)
344
Sell
153
$-5.25 (-3.32%)
135
1 months 19 days ago
20/20 (100%)
$19.5 (30.42%)
515
Buy
163
$4.75 (3.00%)
157
1 months 19 days ago
34/35 (97.14%)
$24.2 (28.52%)
414
Sell
153
$-5.25 (-3.32%)
92
1 months 19 days ago
6/6 (100%)
$25.57 (55.74%)
574
Hold
154
$-4.25 (-2.69%)
157
1 months 19 days ago
4/4 (100%)
$15.03 (18.69%)
198